News
A trial tested MRI and microultrasonography guided biopsy separately and in combination for the detection of clinically significant prostate cancer.
HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial.
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
MRI visibility and the presence of secondary Gleason pattern 4 at baseline are associated with progression to treatment and ...
This study reports DLM's trained with uncertainty estimations, using ran-domly initialized weights and Monte Carlo dropout, to segment tumors from microscopic Hematoxylin and Eosin dye stained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results